NCT02617459

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

A Multicenter, Randomized, Open-label, Positive-controlled, Parallel-group Clinical Trial of Levobetaxolol Hydrochloride Eye Drops in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 366 (actual)
• Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of Levobetaxolol in Chinese patients with glaucoma.

Detailed description

To evaluate the safety and efficacy of Levobetaxolol in Chinese patients with primary open-angle glaucoma or ocular hypertension.

Conditions

• Primary Open-angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Levobetaxolol eye drops	one drop per time; twice daily
DRUG	Betaxolol eye drops	one drop per time; twice daily

Timeline

• Start date: 2019-01-04
• Primary completion: 2021-07-01
• Completion: 2021-07-01
• First posted: 2015-12-01
• Last updated: 2023-05-12

Locations

1 site across 1 country: China